港交所(00388.HK)歡迎首隻主動型ETF上市
港交所(00388.HK)歡迎首隻主動型交易所買賣基金(ETF)——工銀中金美元貨幣市場ETF(股份代號:3011/9011)上市,標誌著香港ETF市場發展又一里程碑。
主動型ETF有別於傳統ETF,主要由基金經理揀選股份,並以跑贏市場指數為目標。而傳統ETF的管理方式一般屬於被動形,目的是複製所追蹤指數的表現。
港交所高級副總裁及交易所買賣產品主管羅博仁稱,主動型ETF除了具備超越指數表現的潛力,同時亦具有傳統ETF方便、低成本及交易時段內任何時間均可買賣等優點。
2019年香港ETF成交量由1月的620億元倍增至5月的1,300億元,反映市場對ETF產品的興趣正在不斷提升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.